Autoimmunity, hyperstimulation of the immune system, can be caused by a variety of
reasons. Viruses are thought to be important environmental elements that contribute to the …

The thrombopoietin receptor agonists (TPO-RAs) romiplostim, eltrombopag, avatrombopag,
and lusutrombopag carry unique US Food and Drug Administration (US FDA)-and European …

With the recent outbreak of the COVID-19 pandemic and emergency use authorization of
anti-SARS-CoV-2 vaccines, reports of post-vaccine immune thrombocytopenia (ITP) have …

Immune thrombocytopenia (ITP) is characterized by a platelet count less than 100× 10^ 9/L
without anemia or leukopenia. Patients with ITP may be asymptomatic, or they may have …

The management of immune thrombocytopenia (ITP) and the prediction of patient response
to therapy still represent a significant and constant challenge in hematology. ITP is a …

Immune thrombocytopenia (ITP) is an autoimmune disease characterized by platelet
destruction and reduced platelet production resulting in decreased platelet level and an …

Purpose. ITP is the most prevalent autoimmune blood disorder. The lack of predictive
biomarkers for therapeutic response is a major challenge for physicians caring of chronic …

Idiopathic thrombocytopenic purpura (ITP), also known as immune thrombocytopenia, is a
blood disorder characterized by a reduction in the number of platelets. A reduction in the …

In recent years the critical role of miRNAs has been established in many diseases, including
autoimmune disorders. Immune thrombocytopenia purpura (ITP) is a predominant …

Immune thrombocytopenia (ITP) is an autoimmune disorder characterized by platelet count
less than 100× 10 9/L and an increased risk of bleeding. The risk of bleeding increases in …